Antineoplastic AgentsCell Line, TumorDoxorubicinDrug Screening Assays, AntitumorDrug Resistance, NeoplasmAntibiotics, AntineoplasticApoptosisXenograft Model Antitumor AssaysCisplatinDrug SynergismTumor Cells, CulturedNeoplasmsMice, NudePaclitaxelCell SurvivalAntineoplastic Agents, PhytogenicDrug Resistance, MultipleEtoposideP-GlycoproteinNeoplasm TransplantationCell ProliferationFluorouracilAntineoplastic Agents, AlkylatingDose-Response Relationship, DrugNeoplasms, ExperimentalAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsInhibitory Concentration 50Drug Delivery SystemsProto-Oncogene Proteins c-bcl-2Breast NeoplasmsMice, Inbred BALB CTumor Suppressor Protein p53Gene Expression Regulation, NeoplasticCell CycleDaunorubicinMice, SCIDCamptothecinMelanoma, ExperimentalCaspasesLung NeoplasmsDNA DamageColonic NeoplasmsVinblastineLeukemia P388DeoxycytidineDrug ResistanceVincristineTransplantation, HeterologousRNA, Small InterferingCell DivisionBlotting, WesternMitomycinApoptosis Regulatory ProteinsCaspase 3Flow CytometryCyclophosphamideSignal TransductionTNF-Related Apoptosis-Inducing LigandCell DeathTransfectionNeoplasm ProteinsDrug CarriersMultidrug Resistance-Associated Proteinsbcl-X ProteinMice, Inbred C57BLImmunotherapyMelanomaEnzyme InhibitorsTumor BurdenSarcoma 180Ovarian NeoplasmsTime FactorsBleomycinMitoxantroneDacarbazineTaxoidsLeukemia L1210Combined Modality TherapyProdrugsDrug Evaluation, PreclinicalAdenocarcinomaAntibodies, MonoclonalCarmustineReceptors, TNF-Related Apoptosis-Inducing LigandTeniposideNanomedicineLiver NeoplasmsFibrosarcomaDown-RegulationKB CellsMethotrexateOrganoplatinum Compoundsbcl-2-Associated X ProteinNeuroblastomaCell LineAngiogenesis InhibitorsGenetic TherapyEnzyme ActivationUp-Regulation